Hypopituitarism and hypothyroidism following atrioventricular block during nivolumab treatment

J Dermatol. 2017 Jun;44(6):e144-e145. doi: 10.1111/1346-8138.13797. Epub 2017 Mar 11.

Authors

Tomoko Oda¹, Yu Sawada¹, Etsuko Okada¹, Takashi Yamaguchi¹, Shun Ohmori¹, Sanehito Haruyama¹, Manabu Yoshioka¹, Motonobu Nakamura¹

Affiliation

¹ Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan.

PMID: 28295551
DOI: 10.1111/1346-8138.13797

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Antineoplastic Agents, Immunological / adverse effects*
Atrioventricular Block / chemically induced*
Atrioventricular Block / complications
Humans
Hypopituitarism / blood
Hypopituitarism / diagnosis
Hypopituitarism / etiology*
Hypothyroidism / blood
Hypothyroidism / diagnosis
Hypothyroidism / etiology*
Male
Melanoma / diagnosis
Melanoma / drug therapy
Nivolumab / adverse effects*
Skin Neoplasms / diagnosis
Skin Neoplasms / drug therapy

Substances

Antineoplastic Agents, Immunological
Nivolumab